Ketamine Side Effects: Is Ketamine Therapy Safe?

Ketamine therapy has become a mainstream option for treatment-resistant depression, anxiety, PTSD, and some chronic pain conditions, and most people considering it ask the same question before booking a first appointment: is ketamine therapy safe? The short answer is that at the doses and monitoring standards used in clinical treatment, ketamine has a well-established safety record — it has been used in medicine since the 1970s, first as a surgical anesthetic. But "safe" doesn't mean "risk-free." Ketamine produces real, sometimes uncomfortable side effects during treatment, carries genuine long-term considerations with repeated use, and isn't appropriate for everyone. This guide covers what the research and clinical practice actually show, so you can have an informed conversation with a provider rather than relying on one clinic's marketing copy. None of it is meant to talk you into or out of treatment — it's meant to match what's actually documented in the anesthesia and psychiatric literature against what you're likely to hear at an intake appointment.

Ketamine Side Effects at a Glance

Here's the short, scannable version before the detailed sections below: ketamine side effects split into two very different tiers — things that happen to nearly everyone and pass quickly, and things that are rare but worth understanding before you book a first appointment. Each item here gets a fuller explanation further down the page.

What most people notice during or shortly after a session:

• A dissociative, floating, or "not quite here" feeling that fades as the medicine wears off
• Nausea, more likely at higher doses or on an empty stomach
• A short rise in blood pressure and heart rate during dosing
• Dizziness, blurred vision, or a metallic taste
• Drowsiness or grogginess for the rest of the day
• Increased salivation or a mild headache

Rare, but worth knowing before you start treatment:

• A blood pressure spike serious enough to require slowing or pausing the dose
• A panic or distress response during dosing
• Bladder irritation (ketamine cystitis), tied almost entirely to frequent, high-dose use outside a clinical setting
• Cognitive or memory changes, documented mainly in heavy, long-term recreational use rather than monitored treatment
• Tolerance, or needing higher doses over time, with frequent long-term use

That gap between the two tiers comes down to dose and frequency more than the drug itself. A clinic-administered dose is a small, carefully measured fraction of what's used in surgery, given once every few days under a clinician's supervision rather than daily and unsupervised. Most of what shows up in medical literature about serious harm — bladder damage, dependence, cognitive decline — comes from people using ketamine recreationally, often daily, at doses far beyond anything a treatment protocol allows. That doesn't make the risk at therapeutic doses zero, but it does mean the picture you'll actually encounter in a monitored clinic looks different from what a general search on ketamine harm might suggest. Knowing which tier you're in also shapes decisions further down this page, like which delivery method to expect and what a clinic's monitoring should look like before you say yes to treatment. The same logic applies to the broader ketamine risks covered later in this guide — dosage and supervision, not the drug alone, separate a manageable side effect from a genuine hazard.

Ketamine Therapy Side Effects

Most people who go through ketamine therapy notice at least one side effect during or shortly after a session, and that's expected rather than a warning sign. Ketamine is a dissociative anesthetic — the altered state it produces is part of how the medicine works at the doses used for depression and other mental health conditions, not evidence that something has gone wrong. A clinic's job is to dose carefully enough to produce a therapeutic effect while keeping blood pressure, heart rate, and breathing inside a safe range for the length of the appointment.

Context matters here. Ketamine has decades of safety data behind it because it's one of the most widely used anesthetics in the world, given at much higher, sustained doses in surgical settings than a psychiatric infusion ever uses. The doses used for depression, anxiety, or pain are a fraction of a surgical anesthetic dose — often called a "subanesthetic" dose — and delivered once every few days rather than continuously. That's a large part of why the side-effect profile at treatment doses is milder and more predictable than what you'd see in an operating room.

It helps to separate two categories. The first is expected, self-limited effects: dissociation, nausea, a temporary rise in blood pressure, dizziness, and drowsiness afterward. These show up in the large majority of sessions and typically resolve within the appointment window or shortly after. The second category is less common — a genuine adverse reaction, such as a blood pressure spike well above a patient's safe threshold, a panic response, or a reaction that requires the clinical team to slow the infusion or stop the session outright. This second category is the entire reason legitimate ketamine clinics have a clinician monitoring every dose rather than leaving patients unsupervised.

The side-effect pattern is fairly consistent across clinical trials and published case series, which is part of why regulators approved esketamine (Spravato) with a mandatory in-clinic monitoring requirement rather than for unsupervised home use. Knowing what's typical — and what should prompt you to say something to your care team — is the most useful thing to walk into a first session with.

Common Short-Term Side Effects

These are the effects reported most often in ketamine treatment, whether it's given by infusion, injection, or nasal spray:

• Dissociation: a sense of detachment from your body or surroundings, a distorted sense of time, or a dreamlike, floating quality to your thoughts. This is the core drug effect at treatment (subanesthetic) doses, usually most intense partway through dosing and fading as the medicine wears off.
• Nausea: one of the most commonly reported side effects, more likely at higher doses or on an empty stomach. Many clinics offer or pre-treat with an anti-nausea medication if you have a history of motion sickness or nausea with anesthesia.
• A rise in blood pressure and heart rate:ketamine's cardiovascular effect means a temporary increase during dosing is expected, which is the main reason vital signs are checked before, during, and after treatment.
• Dizziness or blurred vision: usually transient and clears during the observation period after dosing.
• Increased salivation or a metallic taste: a less-discussed but well documented effect of ketamine, generally mild and not a cause for concern on its own.
• Drowsiness and fatigue:many patients feel sleepy or foggy for the rest of the day, which is why you shouldn't drive yourself home or return to safety-sensitive work the same day.
• Less commonly: increased anxiety or emotional intensity, a mild headache, or vivid perceptual changes. Some patients describe visual or sensory distortions at higher doses; true hallucinations — perceiving something with no basis in reality once the medicine has cleared — are uncommon and typically resolve completely once the session ends.

Nearly all of these effects are confined to the dosing session and the recovery period that follows — typically 30 minutes to two hours depending on the delivery method — which is why every legitimate protocol includes supervised recovery time and a rule against driving yourself afterward.

Does the Delivery Method Change What You Experience?

Ketamine infusion side effects, IM injection side effects, and the effects of Spravato nasal spray overlap heavily — the drug is doing similar things in the body — but how it's delivered changes how controllable and how immediate those effects are.

• IV infusion:a clinician sets the dose and controls the rate in real time over roughly 40–60 minutes, and can slow or pause the infusion if blood pressure climbs too high or dissociation becomes uncomfortable. That real-time control makes IV the most adjustable format, which is one reason it's the default choice at many mental-health and pain clinics.
• IM injection: the full dose is given at once rather than titrated, so onset is faster and effects can feel more abrupt, with less opportunity to adjust mid-dose than with an infusion.
• Spravato (esketamine nasal spray):the only ketamine-based option with FDA approval for depression, and it can only be given at a REMS-certified clinic, where you self-administer the spray and then stay for roughly two hours of observation. Its side-effect profile mirrors generic ketamine's — dissociation, sedation, nausea, and a blood pressure increase are all listed in the FDA prescribing information — but that built-in monitoring requirement is also part of why it's more consistently covered by insurance than infusion-based ketamine.
• Oral ketamine or troches:produces the lowest peak blood levels of the common formats and generally milder subjective effects, but it's typically taken at home as part of a telehealth program rather than in a monitored clinic setting, which shifts more of the responsibility for recognizing a problem onto the patient and a support person at home.

Session length reflects that difference in control, too. An IV visit plus recovery typically runs about 1.5–2 hours at the clinic; an IM appointment is often shorter, but the whole dose lands at once. Spravato's REMS-mandated observation alone runs about two hours after a briefer dosing period. Oral programs have no in-clinic time at all beyond periodic prescriber check-ins, which is convenient but means less direct supervision if something feels wrong.

Comparing how each treatment type is actually administered can help you weigh the tradeoffs that matter to you, from monitoring level to cost — including whether your insurance is likely to cover it.

Long-Term Considerations

Questions about the long-term effects of ketamine therapy usually come down to two things: what repeated dosing does to the body, and whether the drug carries a dependency risk.

The best-documented physical risk associated with long-term ketamine exposure is bladder and urinary-tract irritation, sometimes called ketamine-induced cystitis, which can cause urinary urgency, frequency, pelvic pain, or blood in the urine. It's worth reading the research on this carefully: nearly all of the published case reports describing it come from people using ketamine recreationally — frequently, often daily or near-daily, over months or years, at cumulative doses far above what a monitored treatment protocol involves. A structured course of ketamine therapy — a defined induction series followed by occasional, spaced booster sessions set by a prescriber — is a very different exposure pattern than daily illicit use. That difference doesn't mean the risk is zero at any dose; it means the risk tracks with dose and frequency. Anyone in ongoing ketamine treatment, especially a long course of maintenance boosters, should tell their care team promptly about any new urinary symptoms so they can be evaluated.

On dependency: ketamine is a Schedule III controlled substance in the US, a classification that reflects a recognized, moderate potential for misuse — lower than Schedule I or II drugs, but real. That's part of why legitimate treatment is structured rather than open-ended. A prescriber sets your induction series and any booster schedule, and at-home oral programs typically dispense limited quantities with regular check-ins rather than large supplies for self-directed use. If you're planning an extended course of treatment, it's reasonable to ask your clinic directly how they monitor for these long-term patterns.

There's also a documented pattern of tolerance with frequent, heavy use — needing progressively higher doses to get the same effect — which is another reason legitimate protocols space out and cap dosing rather than allowing daily self-administration. Cognitive effects such as memory problems have been described in heavy, long-term recreational users, but that pattern hasn't been shown at the dosing frequency and cumulative exposure used in a standard treatment course. It's still a fair question to raise with your prescriber if you're on an extended maintenance schedule.

Monitoring and Safeguards at Legitimate Clinics

Most of the risk in ketamine therapy is manageable with the right oversight, which is why a clinic's monitoring standard matters as much as the medicine itself. At a minimum, a legitimate provider should have:

• Medical and psychiatric intake screening — health history, current medications, and a review for the conditions covered below — before you're ever dosed.
• Baseline vital signs, then blood pressure, heart rate, and oxygen checks at intervals throughout dosing.
• A licensed clinician — an MD, DO, NP, PA, or CRNA, or a nurse working under one — present for the entire dosing and recovery period, not just a check-in at the start.
• A private recovery area and a firm rule that you don't drive yourself home.
• An emergency protocol and the equipment to act on it, even though serious reactions are uncommon at treatment doses.
• For Spravato specifically, REMS enrollment — the FDA-mandated program requiring certified clinics, in-office administration, and monitored observation.
• A follow-up check-in after each session, by phone or in person, to track how side effects and symptoms are trending across your treatment course rather than treating every visit as a one-off.

Oversight varies more between clinics than most patients expect, since — outside of Spravato's REMS requirement — there's no single federal certification specific to ketamine treatment. It's worth learning how to verify a ketamine provider before you book, so you can confirm licensure and monitoring standards rather than taking a website's word for it.

Who Should Be Cautious About Ketamine Therapy

No medication is right for everyone, and ketamine has genuine contraindications. Clinics typically screen for conditions such as:

• Uncontrolled or severe high blood pressure, since ketamine causes a temporary further rise during dosing.
• Certain cardiac conditions, including a recent heart attack, unstable angina, some arrhythmias, or a history of aneurysm.
• A personal history of psychosis or certain psychotic disorders, since the dissociative effect can be destabilizing for some patients.
• Pregnancy or breastfeeding, since ketamine crosses the placenta and passes into breast milk.
• Active, uncontrolled substance use disorder, given the medication's own misuse potential and the importance of a stable support structure during treatment.
• Significant untreated liver disease, since ketamine is processed by the liver, or glaucoma and other conditions involving elevated eye pressure.

Medications and substances matter too, not just diagnoses. Combining ketamine with other sedatives, or with alcohol shortly before or after a session, raises the chance of excessive sedation or impaired coordination and judgment once you leave the clinic. Certain other prescriptions can also interact with ketamine or complicate anesthesia risk. Tell your provider about everything you take — prescriptions, over-the-counter medications, and supplements — not just what feels relevant.

This isn't a complete list, and it isn't medical advice — every clinic's intake screening looks a little different, and the only way to know whether ketamine therapy is appropriate for your specific health history is a full medical and psychiatric review with a licensed clinician. That review is exactly what happens at a first appointment, alongside baseline vitals and a walkthrough of what dosing will actually feel like.

Frequently Asked Questions

None of this replaces a conversation with a licensed clinician who knows your full medical history — the guidance here is meant to help you ask better questions, not answer them for you.

Sources: FDA prescribing information for ketamine and esketamine (Spravato), peer-reviewed clinical-trial data on ketamine's cardiovascular and dissociative effects, and case-series literature on ketamine-associated cystitis in frequent recreational users. Informational only — not medical advice. Talk with a licensed clinician about your health history before starting treatment.